CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
RON and MET Co-overexpression Are Significant Pathological Characteristics of Poor Survival and Therapeutic Targets of Tyrosine Kinase Inhibitors in Triple-Negative Breast Cancer
Tian-Hao Weng, Min-Ya Yao, Xiang-Ming Xu, Chen-Yu Hu, Shu-Hao Yao, Yi-Zhi Liu, Zhi-Gang Wu, Tao-Ming Tang, Pei-Fen Fu, Ming-Hai Wang, Hang-Ping Yao
Cancer Research and Treatment. 2020;52(3):973-986.   Published online 2020 April 22    DOI: https://doi.org/10.4143/crt.2019.726

Excel Download

RON and MET Co-overexpression Are Significant Pathological Characteristics of Poor Survival and Therapeutic Targets of Tyrosine Kinase Inhibitors in Triple-Negative Breast Cancer
Cancer Research and Treatment. 2020;52(3):973-986   Crossref logo
Link1 Link2 Link3

Aberrant RON and MET Co-overexpression as Novel Prognostic Biomarkers of Shortened Patient Survival and Therapeutic Targets of Tyrosine Kinase Inhibitors in Pancreatic Cancer
Frontiers in Oncology. 2019;9:   Crossref logo
Link1

Therapeutic targets of triple-negative breast cancer: a review
British Journal of Pharmacology. 2015;172(17):4228-4237   Crossref logo
Link1 Link2 Link3

New targets for therapy in breast cancer: Small molecule tyrosine kinase inhibitors
Breast Cancer Research. 2004;6(5):   Crossref logo
Link1 Link2 Link3

Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy
Breast Cancer Research. 2015;17(1):   Crossref logo
Link1 Link2 Link3 Link4

Potential Therapeutic Targets in Triple Negative Breast Cancer
Current Breast Cancer Reports. 2015;7(4):215-223   Crossref logo
Link1 Link2 Link3 Link4

Noncoding RNAs as Predictive Biomarkers of Therapeutic Response to Tyrosine Kinase Inhibitors in Metastatic Cancer
Tyrosine Kinases as Druggable Targets in Cancer. 2019;   Crossref logo
Link1

B7-H4 overexpression contributes to poor prognosis and drug-resistance in triple-negative breast cancer
Cancer Cell International. 2018;18(1):   Crossref logo
Link1 Link2 Link3

Fibroblast-secreted hepatocyte growth factor mediates epidermal growth factor receptor tyrosine kinase inhibitor resistance in triple-negative breast cancers through paracrine activation of Met
Breast Cancer Research. 2012;14(4):   Crossref logo
Link1 Link2 Link3

Have all triple-negative breast cancer patients worse breast cancer-specific survival?
The Breast. 2017;36:102   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.